The wildlife health market size is expected to see rapid growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth in the forecast period can be credited to the increasing demand for diverse animal health products, regional opportunities, a rising need for companion animal health products, strategic initiatives by industry leaders, and a heightened demand for veterinary software. Significant trends expected in the forecast period involve worldwide collaboration in disease surveillance, the application of data analytics and artificial intelligence, a proliferation of wildlife conservation measures, programs, and funding activities.
The growth of the wildlife health market is anticipated to be propelled by the increasing incidence of zoonotic diseases. Zoonotic diseases are illnesses or infections that can be transmitted between animals and humans or vice versa. The rise in these diseases is expected to drive the development of various health-related products for wildlife health. For instance, in December 2022, the European Food Safety Authority reported 127,840 cases of zoonotic diseases in Europe in 2021, compared to 120,946 in 2020. Salmonellosis, the second-most reported zoonotic disease, affected 60,050 people in 2022, a significant increase from 52,702 cases in 2020. Thus, the surge in zoonotic diseases is a key factor contributing to the growth of the wildlife health market.
The growth of the wildlife health market is also anticipated to be fueled by wildlife conservation measures and funding activities. Wildlife conservation involves a range of strategies aimed at preserving biodiversity, requiring substantial funding for habitat restoration, anti-poaching efforts, research initiatives, and community engagement. The wildlife health market plays a crucial role in supporting these efforts by providing essential services, diagnostics, and treatments that contribute to the overall well-being of wildlife populations. For instance, in September 2023, the United States Department of the Interior allocated over $40.6 million in grants to 10 states and the U.S. through the U.S. Fish and Wildlife Service, supporting habitat acquisition and protection. Therefore, wildlife conservation measures and funding activities are driving the growth of the wildlife health market.
Advancements in technology represent a significant trend in the wildlife health market. Major companies in the market are adopting new technologies to maintain their competitive position. For example, in August 2021, Merck Animal Health launched WHISPER ON ARRIVAL technology, a specialized sound collection device with a predictive algorithm that analyzes the risk of Bovine Respiratory Disease (BRD). This technology aids farmers and veterinarians in making informed decisions about BRD treatment.
Strategic partnerships are a notable approach adopted by major companies in the wildlife health market to enhance pathogen control in equine environments. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits. In May 2023, the United States Equestrian Federation partnered with Merck Animal Health and ByoPlanet to integrate ByoPlanet's advanced technology with Merck Animal Health's antimicrobial solutions. This collaboration offers a comprehensive approach to enhancing pathogen control in equine environments, addressing wildlife health challenges proactively and introducing innovative products to positively impact the broader wildlife health market, particularly in the equine sector.
In June 2022, Zoetis Inc., a U.S.-based pharmaceutical company, acquired Basepaws for an undisclosed amount. The acquisition of Basepaws is expected to strengthen Zoetis Inc.'s presence in the precision animal health sector and guide future advancements in pet care. Basepaws, a U.S.-based company, specializes in offering DNA tests for cats and dogs.
Major companies operating in the wildlife health market report are Bayer AG, Novartis AG, Merck & Co Inc., Boehringer Ingelheim International GmbH, CSL Limited, Zoetis Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Génia USA Inc., Ceva Santé Animale, Orion Corporation, Virbac Group, Royal Canin, Emergent BioSolutions Inc., Ceva Santé Animale Group, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Dechra Pharmaceuticals, Huvepharma, Vétoquinol, Vetoquinol S.A., Indian Immunologicals Limited, Norbrook Laboratories Limited, Heska Corporation, Biogenesis Bago, Animalcare Group PLC, Pneu-Dart Inc., PetAg Inc.
North America was the largest region in the wildlife health market in 2023. The regions covered in the wildlife health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wildlife health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The primary categories of wildlife health include mammals, birds, fish, reptiles, and amphibians. Mammals denote members of the vertebrate animal family whose offspring are nourished by the mother's milk from specific mammary glands. The products comprise medicine, equipment, and consumables, utilizing various routes of administration such as oral, injectable, and others. The end users encompass zoos, wildlife sanctuaries, wildlife rescue and rehabilitation centers, among others.
The wildlife health market research report is one of a series of new reports that provides wildlife health market statistics, including wildlife health industry global market size, regional shares, competitors with a wildlife health market share, detailed wildlife health market segments, market trends and opportunities, and any further data you may need to thrive in the wildlife health industry. This wildlife health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The wildlife health market consists of sales of immobilizing drugs, pharmaceutical drugs, and vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Wildlife Health Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on wildlife health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for wildlife health? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:1) By Animal Type: Mammals; Birds; Fish; Reptiles; Amphibians
2) By Product: Medicine; Equipment and Consumables
3) By Route of Administration: Oral; Injectable; Other Routes Of Administration
4) By End-user: Zoos; Wildlife Sanctuaries; Wildlife Rescue and Rehab Centers; Other End-users
Key Companies Mentioned: Bayer AG; Novartis AG; Merck & Co Inc.; Boehringer Ingelheim International GmbH; CSL Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Novartis AG
- Merck & Co Inc.
- Boehringer Ingelheim International GmbH
- CSL Limited
- Zoetis Inc.
- Elanco Animal Health Incorporated
- IDEXX Laboratories Inc.
- Génia USA Inc.
- Ceva Santé Animale
- Orion Corporation
- Virbac Group
- Royal Canin
- Emergent BioSolutions Inc.
- Ceva Santé Animale Group
- Phibro Animal Health Corporation
- Dechra Pharmaceuticals PLC
- Dechra Pharmaceuticals
- Huvepharma
- Vétoquinol
- Vetoquinol S.A.
- Indian Immunologicals Limited
- Norbrook Laboratories Limited
- Heska Corporation
- Biogenesis Bago
- Animalcare Group plc
- Pneu-Dart Inc.
- PetAg Inc.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | February 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 2.51 Billion |
Forecasted Market Value ( USD | $ 3.7 Billion |
Compound Annual Growth Rate | 10.2% |
Regions Covered | Global |